Semax vs Selank Together: The Research Case for Stacking One of the most compelling aspects of Semax vs Selank research is their natural complementarity
To move Epitalon from experimental to evidence-based, several developments are essential: Randomized, double-blind, placebo-controlled clinical trials, ideally targeting specific endpoints (sleep, immune aging, telomere attrition) Toxicology and long-term safety studies, including exploration of stereoisomer effects and off-target consequences Validated delivery systems (e.g., dendrimer-conjugates, transdermal patches) that make real-world use feasible Pharmacodynamic biomarkers, to identify responders and track efficacy objectively over time Epitalon is not snake oil, but its also not a magic bullet
Jacob RA, Spinozzi GM, Simon VA, et al
y Medvedjev et al., las inyecciones ICV de dosis ms altas de DSIP (20 nmol/kg o ms) producen efectos similares a la anestesia en diferentes animales